ICEYE signs contract to provide Government of Ukraine with access to its SAR satellite constellation August 18, 2022 7:53 am|The contract signed with the Serhiy Prytula Charity Foundation will initially provide the Government of Ukraine with the…
Riley Decker Companies Promotes Two Team Members to Vice President of Operations August 18, 2022 7:46 am|The family of staffing brands is focused on growth and diversifying their service offerings
Arf receives Swiss regulatory approval August 18, 2022 7:40 am|ZUG, Switzerland, Aug. 18, 2022 /PRNewswire/ — Arf, the global settlement banking platform for licensed money service businesses,…
Record Electric Car Sales as Governments Double Down on Support, Reports IDTechEx August 18, 2022 7:33 am|BOSTON, Aug. 18, 2022 /PRNewswire/ — While 2022 continues to add to the challenges electric vehicle (EV) makers…
Tris Pharma Announces US District Court Upholds Validity of QuilliChew ER® Patents; Rules Teva Infringes Tris Patents August 18, 2022 7:30 am|MONMOUTH JUNCTION, N.J., Aug. 18, 2022 /PRNewswire/ — Tris Pharma, Inc. (“Tris”) a fully integrated pharmaceutical company with a robust portfolio…
Cigna Foundation Commits $3 Million to Help Local Nonprofits Address Childhood Hunger and Mental Health This School Year August 18, 2022 7:30 am|BLOOMFIELD, Conn., Aug. 18, 2022 /PRNewswire/ — The Cigna Foundation today announced more than $3 million in grants to…
Jazz Pharmaceuticals Announces Initiation of Phase 3 Trial Evaluating Epidiolex®/Epidyolex® (cannabidiol) for Patients with Epilepsy with Myoclonic-Atonic Seizures August 18, 2022 7:30 am|Trial is the first randomized, controlled clinical trial evaluating cannabidiol to treat children and adolescents living with a developmental…
Ceragon Urges Shareholders to Vote AGAINST Aviat's Attempt to Take Control of the Board on the WHITE Proxy Card TODAY August 18, 2022 7:30 am|Deadline for voting by proxy is 4:00 pm Israel time on August 22, 2022
European Commission approves Oncopeptides' Pepaxti for the treatment of patients with relapsed refractory multiple myeloma August 18, 2022 7:27 am|STOCKHOLM, Aug. 18, 2022 /PRNewswire/ — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research…
Zhihu Inc. to Report Second Quarter and Half-Year Interim Financial Results of 2022 on August 30, 2022 August 18, 2022 7:20 am|BEIJING, Aug. 18, 2022 /PRNewswire/ — Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), the operator…